Company Profile
AngioDynamics Stock Price, News & Analysis
- Ticker:
- ANGO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, AngioDynamics is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
12.37 USD (-0.16%)
Close
Last updated: June 23, 2026 at 00:00
511.11M USD
Market cap
Why the stock is moving
ANGO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
AngioDynamics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, AngioDynamics is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
AngioDynamics follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, AngioDynamics sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Source: AngioDynamics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of AngioDynamics (ANGO)?
AngioDynamics (ANGO) most recently closed at 12.37 USD, a -0.16% move versus the previous session.
What is the market cap of AngioDynamics (ANGO)?
AngioDynamics currently has a market capitalization of 511.11M USD on BioPharmSignal.
What does AngioDynamics do?
AngioDynamics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ANGO stock listed?
AngioDynamics (ANGO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, AngioDynamics is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is AngioDynamics?
AngioDynamics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is AngioDynamics targeting with AngioDynamics?
AngioDynamics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.